Asian Noble Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
as on 28-06-2024
- Paid Up Capital ₹ 0.10 M
as on 28-06-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 35.00 M
as on 28-06-2024
- Revenue 3.60%
(FY 2022)
- Profit -5.00%
(FY 2022)
- Ebitda -15.64%
(FY 2022)
- Net Worth 58.56%
(FY 2022)
- Total Assets -21.55%
(FY 2022)
About Asian Noble Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹3.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Bapusaheb Kandekar, Sangita Kandekar, and Abhishek Kandekar serve as directors at the Company.
- CIN/LLPIN
U85100PN2016PTC158864
- Company No.
158864
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Ahmed Nagar, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Asian Noble Hospital?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bapusaheb Kandekar  | Director | 16-Mar-2016 | Current |
| Sangita Kandekar | Director | 16-Mar-2016 | Current |
| Abhishek Kandekar | Director | 06-Mar-2021 | Current |
Financial Performance and Corporate Structure Insights of Asian Noble Hospital.
Asian Noble Hospital Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.6% increase. The company also saw a slight decrease in profitability, with a 5% decrease in profit. The company's net worth Soared by an impressive increase of 58.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asian Noble Hospital?
In 2019, Asian Noble Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ahmednagar Cathlab (India) Private Limited
Active
21 years 11 months Bapusaheb Kandekar and Sangita Kandekar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Jun 2019 | ₹3.50 Cr | Satisfied |
How Many Employees Work at Asian Noble Hospital?
Asian Noble Hospital has a workforce of 111 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asian Noble Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asian Noble Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
